AST-platelet ratio index cannot be used in the exclusion of significant fibrosis in chronic hepatitis B patients

References (3)

1. Guzelbulut F, Seziklı M, Çetinkaya ZA, Yaşar B, Özkara S, Kurdaş- Övünç AO. AST-platelet ratio index in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis B. Turk J Gastroenterol 2012; 23: 353-8.
2. Jin W, Lin Z, Xin Y, Jiang X, Dong Q, Xuan S. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis. BMC Gastroenterol 2012; 12: 14. Ishak K, Baptista A, Bianchi L, et al. Histological grading and stag- ing of chronic hepatitis. J Hepatol 1995; 22: 696-9.
3. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-26.